Switch to:

Top Direct Holders

HolderPositionShares% of Shares
Outstanding
Report Date
Rick E. WinninghamCEO825,3910.72%2014-08-15
Dr. George M. Whitesides,PhDN/A606,3770.53%2014-05-22
Michael W. AguiarSr VP, CFO464,8960.4%2015-01-07
Bradford J. ShaferSr VP, Gen. Counsel, Secretary443,0130.38%2014-08-20
Dr. P. Roy Vagelos,M.D.N/A404,8020.35%2009-12-23
Leonard M. BlumSr VP, Chief Comm. Officer401,5380.35%2014-08-20
Mathai Mammen,M.D.,PhDSVP, Research & Early Clin Dev334,0400.29%2014-08-20
Marty GlickExecutive VP, Finance and CFO267,8050.23%2004-10-05
Junning LeeSr. VP, Technical Operations262,1980.23%2014-08-20
Mr. Eric d'EsparbesN/A139,4430.12%2015-01-07

Insider Charts

Insider Transactions

Insider Position Date Buy/Sell Shares Shares Owned Following This (Direct & Indirect) Trade Price ($) Cost ($1000) Price Change
Since Trade (%)
Details
GLAXOSMITHKLINE PLC10% Owner2014-11-04Buy832,45631,581,179$1278650010644198644-100Link
LEE JUNNINGSr. VP, Technical Operations2014-08-13Sell53,424318,883$22.51202-49.91Link
Shafer Bradford JSr VP, Gen. Counsel, Secretary2014-08-12Sell28,156474,430$22.13623.1-49.07Link
GLAXOSMITHKLINE PLC10% Owner2014-08-11Buy172,65130,748,723$3912270675457327.8-100Link
GLAXOSMITHKLINE PLC10% Owner2014-05-09Buy317,77030,576,072$85448402715293806.8-100Link
Shafer Bradford JSr VP, Gen. Counsel, Secretary2014-03-03Sell65,806329,481$36.732417.1-69.32Link
Mammen MathaiSVP, Research & Early Clin Dev2014-02-14Sell35,000186,623$39.361377.6-71.37Link
GLAXOSMITHKLINE PLC10% Owner2014-02-11Buy342,22930,258,302$128507004397882210.3-100Link
GLAXOSMITHKLINE PLC10% Owner2013-10-29Buy130,47329,916,073$4913610641093437.5-100Link
Winningham Rick ECEO
(Click for the stocks that their CEOs have bought)
2013-09-12Sell22,353690,106$40.03894.8-71.85Link
GLAXOSMITHKLINE PLC10% Owner2013-07-30Buy3,064,40729,785,600$111851000342756987357-100Link
Mammen MathaiSVP, Research & Early Clin Dev2013-07-30Sell7,000211,705$36.51255.6-69.13Link
Shafer Bradford JSr VP, Gen. Counsel, Secretary2013-06-07Sell31,038306,166$35.041087.6-67.84Link
Brinkley David LHead of Business Dev.2013-05-29Sell3,80848,749$35.01133.3-67.81Link
Brinkley David LHead of Business Dev.2013-05-13Sell16,12955,000$40.33650.5-72.06Link
Brinkley David LHead of Business Dev.2013-05-03Sell16,12955,000$34.77560.8-67.59Link
Aguiar Michael WSr VP, CFO2013-04-30Sell170,879142,486$33.85775.7-66.66Link
GLAXOSMITHKLINE PLC10% Owner2013-04-30Buy193,56326,721,193$66992201296721120.9-100Link
Mammen MathaiSVP, Research & Early Clin Dev2013-04-30Sell7,000205,976$33.74236.2-66.6Link
Brinkley David LHead of Business Dev.2013-04-30Sell17,10455,000$33.76577.4-66.62Link

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as Conversion of derivative security or Exercise of Options are not included. Insiders are only limited to Officers and/or Directors of the company.

To find out why GuruFocus thinks data on insider trade are interesting, please read:
Also See GuruFocus Insider Trade Screener:

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK